Background

Translumina Therapeutics Private Limited (“Translumina”), a subsidiary of Integris Medtech Limited (formerly known as Integris Health Private Limited) (“Integris Medtech”), Incorporated in 2009. Over the years, Translumina has evolved into the cardiovascular segment of Integris Medtech through a focused build-partner-acquire strategy. Focused on improving patient care, we support healthcare professionals in over 65 countries (as of June 30, 2025)